Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Lawrence Schwartz
Columbia University Health Sciences, Department: Radiation Diagnostic/oncology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Varian Medical Systems
Other : Inventor’s share of license/royalty fees paid through Columbia
Dr. Schwartz is entitled to receive an inventor’s share of license fees and royalties through a license from Columbia University to Varian. Columbia’s Policy on Financial Conflicts of Interest and Research includes royalties above $5,000, even if received through the University, in the definition of “significant financial interest.” Dr. Schwartz received payments in the (b)(4) range from Varian within the past 12 months. Dr. Schwartz continues to conduct research that relates to the lung tumor segmentation algorithm covered by the license. In light of these facts, Columbia has determined that the outcome of this research could affect the value of the license and Dr. Schwartz’s financial interest, and that the design, conduct, and/or reporting of this research could be affected by this financial interest. Columbia's FCOI Committee found the conflict posed a low risk of bias to this grant given multiple factors, including the role of the algorithm licensed to Varian solely as a tool and the limited likelihood that the outcome of the study will drive further royalties.
Integrating Radiomics into S0819 and Lung-MAP, Biomarker Driven Clinical Trials for Lung Cancer
This work will improve drug discovery for promising new classes of therapies by creating innovative response criteria based on volumetric and radiomics signatures developed with prior support by the QIN and now validated in two large multi-site clinical trials studying multiple therapeutic options in the most important histologic types of lung cancer and most commonly used imaging modality, CT. Results are expected to be applied to other tumor types and help match patients to the treatment that works best for them.
Filed on June 25, 2018.
Tell us what you know about Lawrence Schwartz's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Lawrence Schwartz filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Lawrence Schwartz | Columbia University Health Sciences | Conflict of Interest | Keosys | $5,000 - $9,999 |
| Lawrence Schwartz | Columbia University Health Sciences | Conflict of Interest | Varian | $5,000 - $9,999 |
| Lawrence Schwartz | University of Chicago | Conflict of Interest | Varian | $5,000 - $9,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.